Professor Michael Seckl

Awards

AACR International Glaxosmithkline Scholar in training award to SpR. 2001.

Sylvia Lawler Oncology Prize to SpR, Royal Society of Medicine. 2001.

Sylvia Lawler Oncology Prize to PhD Student, Royal Society of Medicine. 2002.

Sylvia Lawler Prize, Royal Society of Medicine. 2005.

External collaborations

London Research Institute, Professor Julian Downward. 2002 -

Columbia University College of Physicians and Surgeons, NY, Dr Steve Birken.

University of Ulm, Germany, Dr Thomas Seufferlein.

Friedrich Miescher Institute, Basel, Dr George Thomas.

Medical College of Virginia, Prof Geoff Krystal.

External committees

MRC clinical fellowships panel, MRC. Co-opted member for oncology. Aug 2006 -

PRC Grants committee, Pancreatic Research Charity. Chair. Aug 2008 -

AICR grants committee, AICR. Committee member. 1 Jun 2008 -

Association of Cancer Physicians Executive, Association of Cancer Physicians. Executive committee member. 2003 - Dec 2006.

MRC Cell and Molecular Medicine: oncology sub-panel, MRC. Panel member. Feb 2006 - Mar 2006.

CR-UK New Agents Committee, CR-UK. Committee member. Aug 2005 -

CR-UK Phase I/II Committee. Jun 1998 - Jun 2005.

Royal Society of Medicine Oncology Section. Council member and President 2003-4. 1 Oct 1991 -

International Society for Gestational Trophoblastic Disease. Executive Committee Treasurer/Secretary 2005-2009 President Elect 2009-2011. 10 Jan 2000 -

British Association of Cancer Research. Executive committee member. Aug 2004 - Aug 2008.

Fellowships

Fellow of the Royal College of Physicians FRCP. 2000 -

Memberships of professional bodies

Member of the Association of Physcians, Association of Physcians. 2000 -

Links with other academic bodies

Visiting Professor, Peking Union Medical College Hospital, Peking China. Fostering collaborations. Mar 2007 -

Guest lectures

Recent developments in managing GTD. University of Nijmegen, Nijmegen, Holland. Oct 2006.

Role of hCG monitoring in Gestational Trophoblastic Disease. HCG meeting Delkenheim, Delkenhein, Germany. Oct 2006.

Management of patients with low level hCG. Glycoprotein hormone conference, Athens, Georgia, Athens, Georgia, USA. Apr 2005.

FGF_2 and a novel form of chemoresistance. Nottingham University, Nottingham. Nov 2005.

Lung Cancer: bench to bedside. University of Virginia, USA. Sep 2003.

Germ Cell Tumuor Management. Nordic Society for Gynaecologic Oncology, Copenhagen, Denmark. Oct 2003.

FGF-2 Smacs small cell lung cancer. University of Liverpool. Dec 2003.

Simvastatin inhibits small cell lung cancer growth in vitro and in vivo. AACR, Orlando, USA. Mar 2004.

FGF-2-induced chemoresistance. University of Southampton. Mar 2004.

Current Optimum management of Ovarian germ cell tumours. 14th International Per Kolstad meeting, Norwegian Radium Institute. 3 Dec 2004.

Management of Gestational Trophoblastic Tumours. International Gynaecologic Cancer Society biennial Meeting, Edinburgh. Oct 2004. Web link

From biology to the development of novel therapies for small cell lung cancer. Christie Hospital and Paterson Institute. 12 Nov 2004.

Management of gestational trophoblastic neoplasia. Finnish Gynaecology Society meeting, Finland. 18 Nov 2004.

Importance of false negative hCG test results. ISSTD Congress, Hong Kong. Oct 2005.

Role of statins in lung cancer. BTOG annual meeting, Dublin. Jan 2006.

Industrial connections

Astazeneca, MRC CASE award. Oct 2008 -

Editorial boards

Gestational Trophoblastic Disease Update, Editor. Oct 2001 -